Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8630429 | Diabetes Research and Clinical Practice | 2017 | 7 Pages |
Abstract
BGTS were prescribed to more than a third of patients treated with oral glucose lowering drugs only, despite accumulating evidence of their limited effectiveness in this population, resulting in substantial economic burden to the healthcare system. Given the estimated potential cost-savings, rational use of BGTS should be encouraged in Portugal.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Teresa Risso, Cláudia Furtado,